Prenosis, Inc.
Prenosis, Inc. is an artificial intelligence company enabling precision medicine in acute care. At Prenosis we believe healthcare should be tailored to individual biology. With our data-driven approach to fast-moving biology in acute care environments, we're ushering in a new era of precision medicine in acute care. Our Immunix™ precision medicine platform generates proprietary biological insights to rapidly develop precision medicine products and enables the real-time delivery of optimal precision therapy in acute care. The platform is based on the world's largest and fastest-growing biomarker-clinical dataset for rapid immune response. Using Immunix™, we created and validated the Sepsis ImmunoScore™, the first FDA-authorized AI diagnostic for sepsis. At Prenosis, we enable the healthcare ecosystem to see people differently. More information at: www.prenosis.com
Industries
Nr. of Employees
small (1-50)
Prenosis, Inc.
Chicago, Illinois, United States, North America
Products
Immunix
A precision medicine platform used for developing and implementing new precision medicine tools in real-time to improve patient care and outcomes.
Sepsis ImmunoScore
An FDA-authorized AI diagnostic tool for sepsis, leveraging biomarkers and clinical data to predict adverse outcomes within 24 hours.
Electronic Medical Records Integration
Allows direct integration of the Sepsis ImmunoScore into hospital Electronic Medical Records for timely interventions.
Immunix
A precision medicine platform used for developing and implementing new precision medicine tools in real-time to improve patient care and outcomes.
Sepsis ImmunoScore
An FDA-authorized AI diagnostic tool for sepsis, leveraging biomarkers and clinical data to predict adverse outcomes within 24 hours.
Electronic Medical Records Integration
Allows direct integration of the Sepsis ImmunoScore into hospital Electronic Medical Records for timely interventions.